SpringWorks will add two FDA-approved products to Merck's portfolio, namely Ogsiveo (nirogacestat), a drug for desmoid tumours – which accounted for all its 2024 revenues of $172 million – and ...

told cattle feeders this week it will no longer buy animals fed a supplement that's designed ... Zilmax manufacturer Merck Animal Health said in an emailed statement Friday that its product ...

Merck & Co., Inc. operates as a healthcare company ... vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Hard on the heels of the disclosure that Merck KGaA is talking to SpringWorks about a possible takeover, a new FDA approval could have sweetened the deal. Stamford, Connecticut-based SpringWorks ...

Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...